We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNB
1626
DELISTED
Dun & Bradstreet
DNB
| $1.14M | ﹤0.01% |
98,645
-449,270
| -82% | -$4.89M |
|
1627
FTI Consulting
FCN
$4.17B
| $1.14M | ﹤0.01% |
5,982
-6,725
| -53% | -$1.27M |
|
|
MCHB
1628
Mechanics Bancorp
MCHB
$3.7B
| $1.13M | ﹤0.01% |
+191,108
| New | +$1.79M |
|
|
LX
1629
LexinFintech Holdings
LX
$242M
| $1.13M | ﹤0.01% |
493,335
-182,138
| -27% | -$442K |
|
1630
Omega Flex
OFLX
$306M
| $1.13M | ﹤0.01% |
10,878
+7,629
| +235% | +$818K |
|
|
PWSC
1631
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $1.13M | ﹤0.01% |
58,800
-285,103
| -83% | -$5.45M |
|
|
NGD
1632
DELISTED
New Gold Inc
NGD
| $1.12M | ﹤0.01% |
+1,041,520
| New | +$1.29M |
|
1633
Protalix BioTherapeutics
PLX
$200M
| $1.12M | ﹤0.01% |
562,139
+411,781
| +274% | +$981K |
|
1634
StepStone Group
STEP
$3.8B
| $1.12M | ﹤0.01% |
+45,304
| New | +$1.04M |
|
1635
Star Bulk Carriers
SBLK
$3.17B
| $1.12M | ﹤0.01% |
+63,500
| New | +$1.22M |
|
1636
Sprouts Farmers Market
SFM
$7.96B
| $1.12M | ﹤0.01% |
+30,600
| New | +$1.07M |
|
|
CTOS.WS
1637
CALL
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
| $1.12M | ﹤0.01% |
166,665
| – | – |
|
|
TMHC
1638
DELISTED
Taylor Morrison
TMHC
| $1.12M | ﹤0.01% |
+22,905
| New | +$986K |
|
1639
Evercore
EVR
$11.5B
| $1.11M | ﹤0.01% |
+9,009
| New | +$1.04M |
|
1640
CALL
Procter & Gamble
PG
$340B
| $1.11M | ﹤0.01% |
7,300
-42,400
| -85% | -$6.39M |
|
|
ABVEW
1641
CALL
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
| $1.11M | ﹤0.01% |
107,213
| – | – |
|
1642
Cabaletta Bio
CABA
$457M
| $1.11M | ﹤0.01% |
85,696
-243,596
| -74% | -$2.64M |
|
|
KLRS
1643
Kalaris Therapeutics
KLRS
$93.7M
| $1.1M | ﹤0.01% |
14,116
| – | – |
|
1644
Identive
INVE
$61.2M
| $1.1M | ﹤0.01% |
130,471
-12,242
| -9% | -$83.5K |
|
|
SPWRW
1645
CALL
SunPower Inc Warrants
SPWRW
$761K
| $1.09M | ﹤0.01% |
103,234
| – | – |
|
1646
Moderna
MRNA
$23.9B
| $1.09M | ﹤0.01% |
9,000
+6,839
| +316% | +$912K |
|
|
PFTAW
1647
CALL
DELISTED
Perception Capital Corp. III Warrant
PFTAW
| $1.09M | ﹤0.01% |
105,067
-25,231
| -19% | -$1.92K |
|
1648
PNC Financial Services
PNC
$100B
| $1.09M | ﹤0.01% |
8,633
-75,110
| -90% | -$9.18M |
|
1649
Evolution Petroleum
EPM
$134M
| $1.09M | ﹤0.01% |
134,557
+74,391
| +124% | +$550K |
|
|
MAG
1650
DELISTED
MAG Silver
MAG
| $1.09M | ﹤0.01% |
+97,424
| New | +$1.21M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.